Their neuroprotective role in ALS is demonstrated by studies showing faster disease onset and decreased longevity in S1R knockout mice [77] and improved prognosis in ALS models treated with S1R ligands [78]. This evidence concerns the gene TMBIM4 and amyotrophic lateral sclerosis.